| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K64610608 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | 0.036 | 0.8 |
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.045 | 0.8 |
| mRNA | CR-1-31B | CTRPv2 | pan-cancer | AAC | 0.0088 | 0.8 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | -0.014 | 0.8 |
| mRNA | SCH-529074 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
| mRNA | A-443654 | GDSC1000 | pan-cancer | AAC | 0.014 | 0.8 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.0097 | 0.8 |
| mRNA | XMD11-85h | GDSC1000 | pan-cancer | AAC | 0.012 | 0.8 |